REGISTERED
on 04 Oct 2022
Last Applicant/ Owned by
465 North Halstead Street
Pasadena
CA
91107
Serial Number
88049386 filed on 23rd Jul 2018
Registration Number
6866551 registered on 04th Oct 2022
Filing Basis
1. use application currently
Disclaimer
NO DATA
ANTIBODIES BY DESIGN
pharmaceuticals, namely, antibodies and proteins for the treatment of oncological and autoimmune diseases and disorders Medical and scientific research and development services for third parties in the field of pharmaceuticals; scientific consulting services for third parties in the field of pharmaceuticals
Classification Information
Class [005]
Pharmaceutical Products
pharmaceuticals, namely, antibodies and proteins for the treatment of oncological and autoimmune diseases and disorders
First Use Date in General
24th Mar 2021
First Use Date in Commerce
24th Mar 2021
Class [042]
Computer & Software Services & Scientific Services
Medical and scientific research and development services for third parties in the field of pharmaceuticals; scientific consulting services for third parties in the field of pharmaceuticals
First Use Date in General
31st Dec 2013
First Use Date in Commerce
31st Dec 2013
Mark Details
Serial Number
No 88049386
Mark Type
No Service Mark
Attorney Docket Number
No TM6144US00
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 17th Mar 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 17th Mar 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 17th Mar 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 17th Mar 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 17th Mar 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 04th Oct 2022 | REGISTERED-PRINCIPAL REGISTER |
| 04th Oct 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 02th Sep 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 01st Sep 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 08th Aug 2022 | STATEMENT OF USE PROCESSING COMPLETE |